148 results on '"Bedel, Aurélie"'
Search Results
2. A French multicenter analytical evaluation of the automated Lumipulse G sNfL blood assay (Fujirebio®) and its comparison to four other immunoassays for serum neurofilament light chain assessment in clinical settings
3. CRISPR editing to mimic porphyria combined with light: A new preclinical approach for prostate cancer
4. Differential Uridyl-diphosphate-Glucuronosyl Transferase 1A enzymatic arsenal explains the specific cytotoxicity of resveratrol towards tumor colorectal cells
5. The risk of microaspiration during oral care in mechanically ventilated patients: A randomised cross-over study comparing two different suction protocols
6. Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria
7. Pigments test strips: A rapid companion test to exclude sub-arachnoid haemorrhage
8. Tau seeds from Alzheimer's disease brains trigger tau spread in macaques while oligomeric‐Aβ mediates pathology maturation
9. Generation of induced pluripotent stem cells-derived hepatocyte-like cells for ex vivo gene therapy of primary hyperoxaluria type 1
10. Tau seeds from Alzheimer's disease brains trigger tau spread in macaques while oligomeric‐Aβ mediates pathology maturation.
11. Resveratrol and capsaicin used together as food complements reduce tumor growth and rescue full efficiency of low dose gemcitabine in a pancreatic cancer model
12. Specific High-Sensitivity Enzymatic Reporter UnLOCKing-Mediated Detection of Oncogenic BCR::ABL1 and EGFR Rearrangements
13. Marked antioxidant effect of orange juice intake and its phytomicronutrients in a preliminary randomized cross-over trial on mild hypercholesterolemic men
14. Bioactive food components for colorectal cancer prevention and treatment: A good match.
15. raw data Cullot G, Boutin J, Fayet S Nat com 2023
16. An Orthotopic Model of Glioblastoma Is Resistant to Radiodynamic Therapy with 5-AminoLevulinic Acid
17. CSF biomarker variability in the Alzheimer's Association quality control program
18. Bioactive food components for colorectal cancer prevention and treatment: A good match
19. ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected
20. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
21. Biomarkers in diabetes mellitus: contributions and discrepancies of new technologies. A case report
22. Recent progress in genome editing for gene therapy applications: the French perspective
23. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview.
24. Les neurofilaments : un nouveau biomarqueur clé pour les cliniciens. Partie 2 : Neurofilaments, un intérêt au-delà des maladies neurodégénératives.
25. Les neurofilaments : un nouveau biomarqueur clé pour les cliniciens. Partie 1 : Intérêt des neurofilaments dans la prise en charge des maladies neurodégénératives.
26. Covichem: A biochemical severity risk score of COVID-19 upon hospital admission
27. Circulating Tumor Cell Clusters: United We Stand Divided We Fall
28. International initiative for harmonization of cerebrospinal fluid diagnostic comments in Alzheimer's disease
29. Cellular and Gene Therapy for Erythropoietic Porphyrias
30. Next-Generation Cancer Biomarkers: Extracellular Vesicle DNA as a Circulating Surrogate of Tumor DNA
31. International initiative for harmonization of cerebrospinal fluid diagnostic comments in Alzheimer's disease
32. Mutation-Specific Guide RNA for Compound Heterozygous Porphyria On-target Scarless Correction by CRISPR/Cas9 in Stem Cells
33. Marqueurs biologiques du diabète : apports et discordances des nouvelles technologies. À propos d'un cas clinique.
34. In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens
35. High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery
36. Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology
37. Tumor‐proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells
38. Combination treatment of resveratrol and capsaicin radiosensitizes pancreatic tumor cells by unbalancing DNA repair response to radiotherapy towards cell death
39. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
40. What are the challenges in 2016 regarding resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and cancer?
41. Are extracellular vesicles able to control human pluripotent stem cell fate?
42. Comparative analysis of Circulating Tumour Cells detection and circulating tumor DNA in liquid biopsy for the diagnosis of early stage pancreatic adenocarcinoma
43. What are the challenges in 2016 regarding resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and cancer?
44. In vitro comparative analysis of Circulating Tumour Cells detection in liquid biopsy for the diagnosis of pancreatic adenocarcinoma
45. Signalisation mitogène des agents pro-athérogènes, implication de la voie beta-caténine
46. Variable Behavior of iPSCs Derived from CML Patients for Response to TKI and Hematopoietic Differentiation
47. FGFR3 has tumor suppressor properties in cells with epithelial phenotype
48. Novel Risk Factors for Premature Peripheral Arterial Occlusive Disease in Non-Diabetic Patients: A Case-Control Study
49. Metabolic Correction of Congenital Erythropoietic Porphyria with iPSCs Free of Reprogramming Factors
50. Induced Pluripotent Stem Cells (iPSC) From Chronic Myeloid Leukemia: Study of BCR-ABL Addiction and Effect of Tyrosine Kinase Inhibitors,
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.